Shattuck Labs (STTK) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Shattuck Labs insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $250K and 2 sold $592K of STTK stock on the open market.
Get emailed when insiders cluster-buy stocks like STTK
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
STTK insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $4K | 2 |
| Q2 2026 | $250K | 1 | $588K | 4 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Shattuck Labs, Inc. insider reported open-market purchases totaling $250K, while 2 insiders reported sales totaling $592K. Among insiders with enough purchase history to measure, Clay B Siegall (Director) has the highest Insider Score at 66. 6 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jul 7SEC | Abhinav A. ShuklaChief Technical Officer | Sell Plan | 41086,380 held (−0%) | $7.01 | $3K | -14.8% | — |
| Jul 2SEC | Arundathy N. PanditeChief Medical Officer | Sell Plan | 30,000136,219 held (−18%) | $7.01 | $210K | -14.8% | — |
| Jul 2SEC | Abhinav A. ShuklaChief Technical Officer | Sell Plan | 23,36586,380 held (−21%) | $7.08 | $165K | -15.7% | — |
| Jul 2SEC | Abhinav A. ShuklaChief Technical Officer | Sell Plan | 10086,380 held (−0%) | $7.07 | $707 | -15.6% | — |
| Jun 11SEC | Clay B SiegallDirector | Buy | 62,500318,608 held (+24%) | $4.00 | $250K | +49.2% | 66 |
| May 14SEC | Arundathy N. PanditeChief Medical Officer | Sell Plan | 30,000166,219 held (−15%) | $6.61 | $198K | -9.7% | — |
| May 14SEC | Abhinav A. ShuklaChief Technical Officer | Sell Plan | 2,03281,258 held (−2%) | $7.01 | $14K | -14.8% | — |
Insiders at Shattuck Labs, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Clay B SiegallDirector | $250K | — | Jun 11, 2026 | 66 |
| Arundathy N. PanditeChief Medical Officer | — | $409K | Jul 2, 2026 | — |
| Abhinav A. ShuklaChief Technical Officer | — | $183K | Jul 7, 2026 | — |
STTK stock: common questions
Are Shattuck Labs, Inc. insiders buying STTK stock?
In the past 12 months, 1 insiders reported open-market purchases of STTK worth $250K. The latest was Director Clay B Siegall bought $250K of STTK at $4.00 — first open-market purchase in our records; raises the stake by 24%.
Are Shattuck Labs, Inc. insiders selling STTK stock?
2 insiders reported sales worth $592K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is STTK's 52-week range?
Over the past year STTK has traded between $1.77 and $8.06. It last closed at $5.97 on Oct 9, 2026.